Praxis Precision Medicines (PRAX) Earnings Date, Estimates & Call Transcripts $45.99 -0.93 (-1.98%) Closing price 08/28/2025 04:00 PM EasternExtended Trading$45.77 -0.22 (-0.48%) As of 07:36 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Praxis Precision Medicines Earnings Summary Praxis Precision Medicines released Q2 2025 & Study Result earnings on August 4, 2025, reporting an EPS of -$3.31, which topped analysts' consensus estimates of -$3.40 by $0.09. With a trailing EPS of -$12.29, Praxis Precision Medicines' earnings are expected to decrease next year, from ($10.22) to ($12.22) per share. Upcoming Q3 2025 & Study Result Earnings DateNov. 5Before Market OpensEstimatedConsensus EPS (Aug. 4) -$3.40 Actual EPS (Aug. 4) -$3.31 Beat By $0.09 Q2 2025 & Study Result Earnings ResourcesQ2 2025 & Study Result Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q) Slide DeckPRAX Upcoming EarningsPraxis Precision Medicines' next earnings date is estimated for Wednesday, November 5, 2025, based on past reporting schedules. Slide DeckFull Screen Slide DeckPowered by Get Praxis Precision Medicines Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Praxis Precision Medicines and other key companies, straight to your inbox. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataPRAX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.PRAX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Praxis Precision Medicines Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$3.18-$2.14-$2.66Q2 20252-$3.83-$2.94-$3.39Q3 20252-$3.78-$3.23-$3.51Q4 20252-$4.25-$3.24-$3.75 FY 2025 8 -$15.04 -$11.55 -$13.30 Q1 20262-$4.23-$2.00-$3.12Q2 20262-$4.50-$2.04-$3.27Q3 20262-$4.60-$2.08-$3.34Q4 20262-$4.64-$2.13-$3.39 Praxis Precision Medicines Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 11/5/2025(Estimated)--------8/4/2025Q2 2025 & Study Result-$3.40-$3.31+$0.09-$3.31$0.15M-5/2/2025Q1 2025-$3.20-$3.29 -$0.09-$3.29$0.20M-2/28/2025Q4 2024-$2.76-$2.94 -$0.18-$2.94$0.36M$7.48M11/6/2024Q3 2024-$2.01-$2.75 -$0.74-$2.75$0.53M$0.30M8/13/2024Q2 2024-$2.38-$1.74+$0.64-$1.74$1.44M$0.36M5/13/2024Q1 2024-$2.01-$2.84 -$0.83-$2.84$2.75M$0.43M3/5/2024Q4 2023-$3.05-$2.97+$0.08-$2.97$0.30M$0.52M11/7/2023Q3 2023-$5.25-$2.70+$2.55-$0.18-$0.47M Praxis Precision Medicines Earnings - Frequently Asked Questions When is Praxis Precision Medicines' earnings date? Praxis Precision Medicines has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 5th, 2025 based off last year's report dates. Learn more on PRAX's earnings history. Did Praxis Precision Medicines beat their earnings estimates last quarter? In the previous quarter, Praxis Precision Medicines (NASDAQ:PRAX) reported ($3.31) earnings per share (EPS) to beat the analysts' consensus estimate of ($3.40) by $0.09. Learn more on analysts' earnings estimate vs. PRAX's actual earnings. How can I listen to Praxis Precision Medicines' earnings conference call? The conference call for Praxis Precision Medicines' latest earnings report can be listened to online. Listen to Conference Call How can I read Praxis Precision Medicines' conference call transcript? The conference call transcript for Praxis Precision Medicines' latest earnings report can be read online. Read Transcript How much revenue does Praxis Precision Medicines generate each year? Praxis Precision Medicines (NASDAQ:PRAX) has a recorded annual revenue of $7.77 million. How much profit does Praxis Precision Medicines generate each year? Praxis Precision Medicines (NASDAQ:PRAX) has a recorded net income of -$182.82 million. PRAX has generated -$12.29 earnings per share over the last four quarters. What is Praxis Precision Medicines' EPS forecast for next year? Praxis Precision Medicines' earnings are expected to decrease from ($10.22) per share to ($12.22) per share in the next year. More Earnings Resources from MarketBeat Related Companies PTC Therapeutics Earnings Lantheus Earnings Arcellx Earnings Akero Therapeutics Earnings Zai Lab Earnings Mirum Pharmaceuticals Earnings MoonLake Immunotherapeutics Earnings Protagonist Therapeutics Earnings Apellis Pharmaceuticals Earnings Metsera Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles NVIDIA's Earnings Show a Green Light for Taiwan Semiconductor After Earnings Miss, Walmart Is Still a Top Consumer Staples PlayRoyal Caribbean Earnings Beat Fuels Strong 2025 OutlookDLocal Stock Soars 43% After Earnings Beat and Raised GuidanceGreen Dot's 30% Rally: Turnaround Takes Off on Explosive EarningsElbit Systems Jumps on Record Earnings and a $1.6B ContractBrinker Serves Up Earnings Beat, Sidesteps Cost Pressures This page (NASDAQ:PRAX) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Praxis Precision Medicines, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Praxis Precision Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access